UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF Journal article
Luo, Dan, Zhao, Jia, Cheng, Yuanyuan, Lee, Simon Ming-Yuen, Rong, Jianhui. N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson's Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF[J]. MOLECULAR NEUROBIOLOGY, 2018, 55(3), 2258-2267.
Authors:  Luo, Dan;  Zhao, Jia;  Cheng, Yuanyuan;  Lee, Simon Ming-Yuen;  Rong, Jianhui
Favorite | TC[WOS]:27 TC[Scopus]:29  IF:4.6/4.7 | Submit date:2018/10/31
Parkinson's Disease  Neuroprotection  N-propargyl Caffeamide (Paca)  Ngf/trkapathway  Pi3k/akt  Erk1/2